Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report
Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by ineffective erythropoiesis, reduced reticulocyte count, normocytic anemia, and the absence of erythroid precursors. Here, we present a rare instance of PRCA occurring after ABO-matched allo-HSCT in a refractory/relapse...
Saved in:
Published in | Annals of hematology Vol. 103; no. 5; pp. 1775 - 1777 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer Berlin Heidelberg
01.05.2024
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by ineffective erythropoiesis, reduced reticulocyte count, normocytic anemia, and the absence of erythroid precursors. Here, we present a rare instance of PRCA occurring after ABO-matched allo-HSCT in a refractory/relapsed acute myeloid leukemia (R/R AML) patient. In this case, the patient received a combination treatment of Gilteritinib, Venetoclax, and Azacitidine. Remarkably, this treatment not only reduced myeloblasts but also facilitated the restoration of erythroid hematopoiesis. |
---|---|
AbstractList | Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by ineffective erythropoiesis, reduced reticulocyte count, normocytic anemia, and the absence of erythroid precursors. Here, we present a rare instance of PRCA occurring after ABO-matched allo-HSCT in a refractory/relapsed acute myeloid leukemia (R/R AML) patient. In this case, the patient received a combination treatment of Gilteritinib, Venetoclax, and Azacitidine. Remarkably, this treatment not only reduced myeloblasts but also facilitated the restoration of erythroid hematopoiesis. Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by ineffective erythropoiesis, reduced reticulocyte count, normocytic anemia, and the absence of erythroid precursors. Here, we present a rare instance of PRCA occurring after ABO-matched allo-HSCT in a refractory/relapsed acute myeloid leukemia (R/R AML) patient. In this case, the patient received a combination treatment of Gilteritinib, Venetoclax, and Azacitidine. Remarkably, this treatment not only reduced myeloblasts but also facilitated the restoration of erythroid hematopoiesis.Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by ineffective erythropoiesis, reduced reticulocyte count, normocytic anemia, and the absence of erythroid precursors. Here, we present a rare instance of PRCA occurring after ABO-matched allo-HSCT in a refractory/relapsed acute myeloid leukemia (R/R AML) patient. In this case, the patient received a combination treatment of Gilteritinib, Venetoclax, and Azacitidine. Remarkably, this treatment not only reduced myeloblasts but also facilitated the restoration of erythroid hematopoiesis. |
Author | Wang, Jiawen Miao, Kourong Zhu, Han |
Author_xml | – sequence: 1 givenname: Jiawen surname: Wang fullname: Wang, Jiawen organization: The first affiliated hospital of Nanjing Medical University, Jiangsu Province Hospital – sequence: 2 givenname: Han surname: Zhu fullname: Zhu, Han organization: The first affiliated hospital of Nanjing Medical University, Jiangsu Province Hospital – sequence: 3 givenname: Kourong surname: Miao fullname: Miao, Kourong email: kourongmiao@163.com organization: The first affiliated hospital of Nanjing Medical University, Jiangsu Province Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38556531$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1u1TAQhS1URG8LL8ACWWLDJtQ_cZywQxUUpErd0HU0Scati2MH2wEuD8hz4dsUkFjgjTWa75wz0jkhRz54JOQ5Z685Y_osMSa0rpioK6Y0r6v9I7LjtRRlbOsjsmOd7CpV3jE5SemOMS7aWjwhx7JVqlGS78jPC-syRputtwMdwzxYjxP9ZvMt_YoecxgdfKfgJwo_YCzcVABqQqQRHSypwDCuGem8RxfsRB2un3G2UMzGNUb0eXNb1ohFM9ERnaOwOEgFAlPSKTgXbkqaHektzpDDEizmMqWM8ybIEXwqIp8h2-Df0BIA6eC4hJifkscGXMJnD_8puX7_7tP5h-ry6uLj-dvLapSiyZVmwgiNfADTdsw0MEoDWphBcGVaPhnGWgM4NRK6QXfdwPUkOt0oVk-q7gZ5Sl5tvksMX1ZMuZ9tOtwHHsOaeslE1_JGqa6gL_9B78IafbmuUFI3jVTiQImNGmNIKaLpl2hniPues_7Qcr-13JeW-_uW-30RvXiwXocZpz-S37UWQG5AKit_g_Fv9n9sfwEmW7p0 |
Cites_doi | 10.1038/s41409-020-01124-6 10.1111/j.1365-2141.2008.07216.x 10.1111/bjh.17463 10.1159/000337022 10.1182/blood-2003-05-1738 10.1056/NEJMoa1807438 10.1111/ejh.13343 |
ContentType | Journal Article |
Copyright | The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
Copyright_xml | – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION K9. NAPCQ 7X8 |
DOI | 10.1007/s00277-024-05714-y |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-0584 |
EndPage | 1777 |
ExternalDocumentID | 10_1007_s00277_024_05714_y 38556531 |
Genre | Journal Article Case Reports |
GrantInformation_xml | – fundername: Miao Kourong grantid: 81470329; 81470329; 81470329 – fundername: Miao Kourong grantid: 81470329 |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C -~X .86 .GJ .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 23M 28- 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6NX 78A 7RV 7X7 88E 8AO 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AACDK AAEOY AAFGU AAHNG AAIAL AAJBT AAJKR AAKSU AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO ABAKF ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKAS ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACAOD ACBMV ACBRV ACBXY ACBYP ACDTI ACGFS ACHSB ACHVE ACHXU ACIGE ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACTTH ACUDM ACVWB ACWMK ACZOJ ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEEQQ AEFIE AEFQL AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFBBN AFEXP AFFNX AFJLC AFKRA AFLOW AFNRJ AFQWF AFWTZ AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BENPR BGNMA BKEYQ BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG EX3 F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ I09 IHE IJ- IKXTQ IMOTQ ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LLZTM M1P M4Y MA- N2Q N9A NAPCQ NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RRX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SCLPG SDE SDH SDM SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TEORI TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW YLTOR Z45 Z7U Z82 Z83 Z87 Z8O Z8V Z8W Z91 ZMTXR ZOVNA ZXP ~EX ~KM AJOOF ALIPV CGR CUY CVF ECM EIF H13 NPM AAYXX CITATION K9. 7X8 |
ID | FETCH-LOGICAL-c326t-702f27e1baf890f6ac3fa72fb215f81df008faed63a9b799b17d2976504d549b3 |
IEDL.DBID | U2A |
ISSN | 0939-5555 1432-0584 |
IngestDate | Sat Aug 17 04:47:21 EDT 2024 Fri Sep 13 09:33:21 EDT 2024 Thu Sep 12 19:40:30 EDT 2024 Wed Oct 09 10:32:07 EDT 2024 Sat Apr 13 05:06:42 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Refractory/relapsed acute myeloid leukemia Allogeneic hematopoietic stem cell transplantation Pure red cell aplasia |
Language | English |
License | 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c326t-702f27e1baf890f6ac3fa72fb215f81df008faed63a9b799b17d2976504d549b3 |
Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
PMID | 38556531 |
PQID | 3037663529 |
PQPubID | 54039 |
PageCount | 3 |
ParticipantIDs | proquest_miscellaneous_3029816559 proquest_journals_3037663529 crossref_primary_10_1007_s00277_024_05714_y pubmed_primary_38556531 springer_journals_10_1007_s00277_024_05714_y |
PublicationCentury | 2000 |
PublicationDate | 2024-05-01 |
PublicationDateYYYYMMDD | 2024-05-01 |
PublicationDate_xml | – month: 05 year: 2024 text: 2024-05-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Berlin/Heidelberg |
PublicationPlace_xml | – name: Berlin/Heidelberg – name: Germany – name: Berlin |
PublicationTitle | Annals of hematology |
PublicationTitleAbbrev | Ann Hematol |
PublicationTitleAlternate | Ann Hematol |
PublicationYear | 2024 |
Publisher | Springer Berlin Heidelberg Springer Nature B.V |
Publisher_xml | – name: Springer Berlin Heidelberg – name: Springer Nature B.V |
References | Sawada, Fujishima, Hirokawa (CR1) 2008; 142 Chapuy (CR6) 2018; 379 Longval (CR2) 2021; 193 Roychowdhury, Linker (CR7) 1995; 16 Marco-Ayala (CR5) 2021; 56 Jung (CR3) 2012; 5 Salas, Alahmari, Lipton (CR4) 2020; 104 Saunthararajah (CR8) 2003; 102 Y Saunthararajah (5714_CR8) 2003; 102 CI Chapuy (5714_CR6) 2018; 379 T Longval (5714_CR2) 2021; 193 DF Roychowdhury (5714_CR7) 1995; 16 K Sawada (5714_CR1) 2008; 142 MQ Salas (5714_CR4) 2020; 104 SH Jung (5714_CR3) 2012; 5 J Marco-Ayala (5714_CR5) 2021; 56 |
References_xml | – volume: 16 start-page: 471 issue: 3 year: 1995 end-page: 472 ident: CR7 article-title: Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin publication-title: Bone Marrow Transpl contributor: fullname: Linker – volume: 56 start-page: 769 issue: 4 year: 2021 end-page: 778 ident: CR5 article-title: Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question publication-title: Bone Marrow Transpl doi: 10.1038/s41409-020-01124-6 contributor: fullname: Marco-Ayala – volume: 142 start-page: 505 issue: 4 year: 2008 end-page: 514 ident: CR1 article-title: Acquired pure red cell aplasia: updated review of treatment publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2008.07216.x contributor: fullname: Hirokawa – volume: 193 start-page: 814 issue: 4 year: 2021 end-page: 826 ident: CR2 article-title: Treatment for pure red cell aplasia after major ABO-incompatible allogeneic stem cell transplantation: a multicentre study publication-title: Br J Haematol doi: 10.1111/bjh.17463 contributor: fullname: Longval – volume: 5 start-page: 110 issue: 1 year: 2012 end-page: 113 ident: CR3 article-title: Successful treatment of pure red cell aplasia with Rituximab in patients after ABO-Compatible allogeneic hematopoietic stem cell transplantation publication-title: Case Rep Oncol doi: 10.1159/000337022 contributor: fullname: Jung – volume: 102 start-page: 3865 issue: 12 year: 2003 end-page: 3870 ident: CR8 article-title: Effects of 5-aza-2’-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease publication-title: Blood doi: 10.1182/blood-2003-05-1738 contributor: fullname: Saunthararajah – volume: 379 start-page: 1846 issue: 19 year: 2018 end-page: 1850 ident: CR6 article-title: Daratumumab for delayed red-cell engraftment after allogeneic transplantation publication-title: N Engl J Med doi: 10.1056/NEJMoa1807438 contributor: fullname: Chapuy – volume: 104 start-page: 145 issue: 2 year: 2020 end-page: 147 ident: CR4 article-title: Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab publication-title: Eur J Haematol doi: 10.1111/ejh.13343 contributor: fullname: Lipton – volume: 56 start-page: 769 issue: 4 year: 2021 ident: 5714_CR5 publication-title: Bone Marrow Transpl doi: 10.1038/s41409-020-01124-6 contributor: fullname: J Marco-Ayala – volume: 142 start-page: 505 issue: 4 year: 2008 ident: 5714_CR1 publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2008.07216.x contributor: fullname: K Sawada – volume: 104 start-page: 145 issue: 2 year: 2020 ident: 5714_CR4 publication-title: Eur J Haematol doi: 10.1111/ejh.13343 contributor: fullname: MQ Salas – volume: 16 start-page: 471 issue: 3 year: 1995 ident: 5714_CR7 publication-title: Bone Marrow Transpl contributor: fullname: DF Roychowdhury – volume: 379 start-page: 1846 issue: 19 year: 2018 ident: 5714_CR6 publication-title: N Engl J Med doi: 10.1056/NEJMoa1807438 contributor: fullname: CI Chapuy – volume: 5 start-page: 110 issue: 1 year: 2012 ident: 5714_CR3 publication-title: Case Rep Oncol doi: 10.1159/000337022 contributor: fullname: SH Jung – volume: 102 start-page: 3865 issue: 12 year: 2003 ident: 5714_CR8 publication-title: Blood doi: 10.1182/blood-2003-05-1738 contributor: fullname: Y Saunthararajah – volume: 193 start-page: 814 issue: 4 year: 2021 ident: 5714_CR2 publication-title: Br J Haematol doi: 10.1111/bjh.17463 contributor: fullname: T Longval |
SSID | ssj0012842 |
Score | 2.4345026 |
Snippet | Pure red cell aplasia (PRCA) is a rare bone marrow (BM) disorder characterized by ineffective erythropoiesis, reduced reticulocyte count, normocytic anemia,... |
SourceID | proquest crossref pubmed springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1775 |
SubjectTerms | Anemia Aniline Compounds Azacitidine - therapeutic use Bone marrow Bone Marrow Diseases - complications Bridged Bicyclo Compounds, Heterocyclic Case Report Case reports Flow cytometry Hematology Hematopoietic Stem Cell Transplantation - adverse effects Hemoglobin Humans Leukemia Leukemia, Myeloid, Acute - complications Leukemia, Myeloid, Acute - therapy Medicine Medicine & Public Health Morphology Oncology Pathogenesis Patients Pyrazines Red-Cell Aplasia, Pure - etiology Stem cell transplantation Steroids Sulfonamides |
Title | Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem cell transplantation: a case report |
URI | https://link.springer.com/article/10.1007/s00277-024-05714-y https://www.ncbi.nlm.nih.gov/pubmed/38556531 https://www.proquest.com/docview/3037663529/abstract/ https://www.proquest.com/docview/3029816559/abstract/ |
Volume | 103 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELaglRAXxLuBUg0SN7CU2HmsuW1RtxWoPbFSOUV-ShHbJGoTieUH8rsY29lUqHAglxwynjxm7PnsLzMm5F1eMoM4oKApV47mQhmqXF5Qxu3CMVsxXvnk5POL8mydf74sLm_zuMPP7jtGMgzUc65bGthGDCkUIUaW0-19su_Bg3flNVvO1AGOt4E6EFzQAo8pU-bvOv6MRncg5h16NESd1WPyaIKLsIz2fULu2fYpeXA-EeLPyK_TxtPdzdC0jQJ8E5zoWgN-dRX8MDZ0eiN_gGwNyJ9SoxzGKguIVMFnsfQ3KCz1OFi42tpN1xjY2PG7vWokKtOxdlPU1o_XFtsY8Ev9IPuQfglhi3Hw5D06om00hBqwXd81PjkSfJXo2GAIRdQ3MmY6tR8Bb4ABFCJn8ZysVydfP53RaWsGqhHvDbRKmWOVzZR0C5G6UmruZMWcQgThEAI7hBZOWlNyKVQlhMoqwxD5FGlucEaq-Auy13atPSBgNDPCOi50ZvJCCVU4xY314i41pUnI-52J6j5W4KjnWsvBoDUatA4GrbcJOdxZsZ56402NYbryyIqJhLydL2M_8h9AtrYbvQwTi6zECVZCXkbrz7fjiwJxL88S8mHnDrfK__0sr_5P_DV5yKJr0jQ7JHvD9WjfIOIZ1BHZX66Ojy_8-fTbl5Oj4PG_AXAHANg |
link.rule.ids | 315,786,790,27957,27958,41116,41558,42185,42627,52146,52269 |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSMAF8SalwCBxA0uJnceaW4VaFuj21JV6i-zYlqJuk6ibSCw_kN_VsZ0EodIDuWY8TjK25xt_mTEhH9KcacQBGY25sjQVSlNl04wybhaWmYLxwiUnr07z5Tr9fp6dj0lh2-lv94mS9Cv1nOwWe7oRfQpFjJGkdHeX3HP11F3ItWaHM3eAC67nDgQXNMNrTJX5t46_3dENjHmDH_Vu5_gxeTTiRTgMBn5C7pjmKbm_GhnxZ-T319rx3XVfN7UCfBOMdI0Gt70Kbh3r22ojf4JsNMhfskI5dFYGEKqCS2Pptigsq6E3cLkzm7bWsDHDhbmsJSqrQvGmoK0brgy20eD2-kF2Pv8S_Bnj4Nh7HImmrsAXgW27tnbZkeDKRIcGva-ivpEh1an5DNgBelAIpMVzsj4-OvuypOPZDLRCwNfTImaWFSZR0i5EbHNZcSsLZhVCCIsY2CK2sNLonEuhCiFUUmiG0CeLU40hqeIvyF7TNuYVAV0xLYzlokp0mimhMqu4Nk7cxjrXEfk4majsQgmOci627A1aokFLb9ByF5GDyYrlOB23JfrpwkErJiLyfr6NE8l9ANmYdnAyTCySHCOsiLwM1p-744sMgS9PIvJpGg5_lN_-LPv_J_6OPFierU7Kk2-nP16ThywMUxonB2SvvxrMG4Q_vXrrR_s19hoBIw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtUwELWglSo2UN6BFozEDtwmdh7X7Kq2t4XSigWVyiryU4p6m0RtInH7gXwXYzsJj8ICkW3Gk4fHnuMcnwlCr9OcasABGYmZtCTlUhNp04xQZmaWmoKywomTj0_yw9P0w1l29pOK3-92HynJoGlwVZrqbrvVdnsSvsWeeoT8QgBvJClZ3karKQxbiPHVnYMvR_sTkwDTr2cSOOMkg2MQzvzZy6_J6QbivMGW-iQ0v4fEePth78n5Vt_JLXX9W2XH_3m-dXR3QKh4J4TUfXTL1A_Q2vHAwT9E3w4qx7BXXVVXEoNvWFsbjd0HXexmzq5RC_EVi1pjcS0U2EF6NBjAMXbCmfYKjIXqO4MvlmbRVBovTH9uLioBzlQoFxW8tf2lgTYaO3YBi9YrPrH_qzl2-wUg9k2lsC8727RN5fSY2BWmDg06X7d9IYK4qn6H4QKQs3GgSR6h0_n-591DMvwNgiiAmB0pYmppYRIp7IzHNheKWVFQKwG0WEDdFtCMFUbnTHBZcC6TQlMAW1mcalgES_YYrdRNbZ4irBXV3FjGVaLTTHKZWcm0ceY21rmO0JsxDMo2FP0op_LOvmtK6JrSd025jNDGGCnlMAFclYAMCgfmKI_Qq-k0DF33AkRtmt7ZUD5LcljTRehJiLDpcmyWAdRmSYTejtHyw_nf7-XZv5m_RGuf9ublx_cnR8_RHRrijcTJBlrpLnuzCXirky-GIfUdLPonNg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Gilteritinib+combined+with+venetoclax+and+azacitidine+for+relapsed+acute+myeloid+leukemia+cocurrent+with+pure+red+cell+aplasia+after+allogeneic+hematopoietic+stem+cell+transplantation%3A+a+case+report&rft.jtitle=Annals+of+hematology&rft.au=Wang%2C+Jiawen&rft.au=Zhu%2C+Han&rft.au=Miao%2C+Kourong&rft.date=2024-05-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0939-5555&rft.eissn=1432-0584&rft.volume=103&rft.issue=5&rft.spage=1775&rft.epage=1777&rft_id=info:doi/10.1007%2Fs00277-024-05714-y&rft.externalDocID=10_1007_s00277_024_05714_y |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0939-5555&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0939-5555&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0939-5555&client=summon |